Flow Cytometry
Customize your policy alerts
Sign up for avalon_healthcare_solutions Policy AHS-F2019 alerts
Get alerted when Policy AHS-F2019 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and reimbursement of flow cytometry, including immunophenotyping, cell enumeration, specimen and marker limits, and DNA content or S-phase testing. It applies to members whose benefits are subject to Avalon Healthcare Solutions policy and to applicable Medicare or Medicaid government coverage requirements.
The policy expanded the covered indication for cytopenias, lymphomas, leukemia, myeloproliferative and lymphoproliferative disorders, or myelodysplastic syndrome and removed repetitive chronic lymphocytic leukemia and chronic myeloproliferative disorder criteria.
CPT code 88199 was removed from the policy.
The policy added a noncoverage statement for flow cytometry-derived DNA content, DNA index, S-phase fraction, or percentage S-phase used for prognostic or therapeutic purposes in routine cancer management.
Flow cytometry for minimal residual disease is covered in accordance with Avalon Policy AHS M2175-Minimal Residual Disease (MRD).
The policy removed molar pregnancy as a flow cytometry indication because molar pregnancy screening is no longer performed by flow cytometry.
The organ transplantation indication was revised to include both preoperative and postoperative monitoring.
The policy clarified that codes 88187, 88188, and 88189 must not be used together for a single specimen.
The policy added that codes 88187, 88188, and 88189 are reimbursed at one unit per specimen for up to two specimens per date of service.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.